Blue, Thomas R.Gordon, Michael S.Schwartz, Robert P.Couvillion, KathrynVocci, Frank J.Fitzgerald, Terrence T.O’Grady, Kevin E.It has been estimated that approximately 15% of people who are incarcerated in the US have histories of opioid use disorder. Relapse to opioid use after release from prison poses a serious risk of HIV infection. Prison-initiated buprenorphine may help to reduce HIV infection given the association between opioid use and HIV-risk behaviors.en-USHiv-risk behaviorBuprenorphinePrisonOpioid use disorderCorrectional settingsLongitudinal analysis of HIV-risk behaviors of participants in a randomized trial of prison-initiated buprenorphineArticle